



This paper focuses on tissue engineering (TE) from
the biomaterialist’s point of view. With the aim of
answering some simple but key questions about TE,
the related literature is here reviewed. In order to
obtain an engineered tissue the following steps are
mandatory: (a) cell selection, (b) identification of the
ideal three-dimensional scaffold for cell seeding and
proliferation, (c) choice of the most suitable type of
cell culture. Whereas the biotechnologist working in
the TE field is responsible for optimizing the cell see-
ding and culture, the biomaterialist has the challen-
ging task of optimizing the three-dimensional cell sup-
port, or scaffold. Therefore, in the present paper, scaf-
fold properties, biomaterials and fabrication technolo-
gies are analyzed in depth and reviewed on the basis of
the current literature. Finally, mention is also made of
the most recently emerging and innovative technolo-
gies relating to scaffolds for TE applications.
Key Words: tissue engineering, natural polymer, bio-
ceramics, scaffold production.
Introduction
It is exactly 20 years since tissue engineering (TE) was
first presented as a promising new field that combined
the principles of biology and materials science in order
to address one of the most important and still unre-
solved problems in human health, namely the loss or
disease of organs and tissues (1). 
Although TE has, ever since then, received more and
more attention from the scientific community as a
consequence of considerable investments by both
government and private companies, it remains a new
field whose rules and principles are still mostly unde-
fined (2, 3).
The basic principles of TE are difficult to identify
mainly because they are extremely dependent on the
biological tissue needing to be replaced. In fact, research
into the regeneration of some tissues such as, for exam-
ple, human skin, has obtained significantly superior
results compared with research into other tissues.
Pathologies of both the soft and hard tissues of the ske-
letal system, as a consequence of trauma or degenera-
tion, are unfortunately very common and difficult to
resolve. TE, in last two decades, has emerged as a pro-
mising approach to orthopedic repair (4-8).
That said, what is a TE approach? What are the basic
principles underlying TE, and how it is possible to re -
generate tissues using a TE approach?
In this review paper, we try to provide concise answers
to these questions, focusing essentially on the two
most important aspects for a biomaterialist: the bio-
materials and the scaffold fabrication technologies.
As schematically reported in Figure 1, in order to indu-
ce tissue regeneration it is necessary (a) to select the
type of cells to be used (primary or immortalized), (b)
to choose a scaffold able to guarantee cell survival, pro-
liferation and differentiation, (c) to establish which cell
culture method to use (static or dynamic using a bio-
reactor).
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While the main task of the biotechnologist is to opti-
mize the cell seeding and culture, the biomaterialist’s
mission, instead, is to optimize the framework that has
to support the cells, i.e. the scaffold. In order to opti-
mize the scaffold, it is very important to define the
properties that it must exhibit, and to be familiar with
the materials that can be used and the technologies
available for scaffold fabrication. 
All these aspects are individually discussed in the fol-
lowing sections.
Scaffold properties
The scaffold is the three-dimensional structure onto
and within which cells must adhere, proliferate, diffe-
rentiate and produce extracellular matrix (ECM). In
order to fulfill its advanced and sophisticated func-
tions – it has to interact actively with the host’s cells,
transmitting signals useful for their sustenance –, it
must be more than a mere mechanical support; for this
reason, scaffolds have to exhibit very specific proper-
ties. Although scaffold properties are strictly related to
the properties of the tissue that is to be regenerated,
some of them, being fundamental, are common to all
scaffolds. These common scaffold properties are: bio-
compatibility, biodegradability, mechanical strength
and porosity (9). 
Biocompatibility
A scaffold is biocompatible when it can be implanted
in a human body without inducing any radical chan-
ge in the intensity and duration of the optimal wound
healing process (10). The nature of the scaffold, i.e.
biomaterial composition, surface charge and rough-
ness, porosity and biodegradability, influences signifi-
cantly the inflammatory response, as do the extent of
the incision made for the implantation and the
implant size and shape. A good biodegradable and bio-
compatible scaffold will allow new tissue replacement
without inducing any fibrous capsular generation. A
non-biocompatible scaffold is toxic to the host tissue,
i.e. it can be rejected and cause death of the surroun-
ding tissues. Biocompatibility tests, serving to esta-
blish the non-toxicity of a scaffold, are a mandatory
preliminary step in a scaffold optimization process.















The scaffold should degrade in order to allow the new
tissue to regenerate easily and restore the defect area.
The degradation rate should match the tissue regene-
ration rate: the scaffold must not disappear too fast as
it has to guarantee the important initial mechanical
support; however, if scaffold degradation is too slow,
its colonization by the new tissue could be compromi-
sed. The perfect scaffold remains as long as its scaffol-
ding action is necessary for cell colonization, prolifera-
tion and differentiation, but it must have completely
disappeared by the end of the regeneration process (9).
Mechanical strength
The mechanical properties of a scaffold should be as
similar as possible to those of the host tissue needing
to be regenerated. Since mechanical properties similar
to those of the target tissue are not easily obtained,
scaffolds should at least be able to withstand handling
by the surgeon during implantation and the compres-
sive and tensile loads occurring in the physiological
environment. Although the above-described mechani-
cal requirements are desirable for all TE applications,
adequate mechanical strength is mandatory for ortho-
pedic applications (9, 11). In order to determine accu-
rately the mechanical properties of a scaffold, care
must be taken to select the proper mechanical test.
The composition and the function of the tissue nee-
ding to be restored will provide indications helping to
determine the most suitable test to perform, i.e. com-
pression or tensile, stress-relaxation, creep or stress-
strain, static or dynamic, etc.
We wish to underline that making a scaffold with the
appropriate mechanical properties is one of the cru-
cial points in orthopedic TE and remains an open
challenge.
Porosity
In order to allow (a) cell colonization and proliferation
and (b) exchange of nourishment and waste products,
the scaffold has to be highly porous and, moreover,
feature a highly interconnected porosity. Pore size, too,
plays an important role in cell survival and differentia-
tion. The pore has to be big enough to allow cells to
penetrate into the scaffold and to colonize the entire
three-dimensional structure; at the same time, it must
not be too big, as the scaffold is required to guarantee
an adequate specific surface area necessary to provide a
binding site for the cells. The ideal pore size will be
strictly related to the site to be regenerated and to the
cell type that is to be used. Therefore, it is not possible
to indicate a single pore size suitable for all tissue engi-
neered scaffolds (9, 11, 12). 
Biomaterials
One of the most important steps in the fabrication of
a scaffold able to promote the regeneration of a tissue
needing to be restored is the choice of material.
Depending on the location, in the human body, of the
tissue that needs to be replaced, some of the important
properties illustrated above become essential and pro-
vide useful indications as to the material that should
be used for the scaffold fabrication. To regenerate a
large portion of bone tissue, for example, it is neces-
sary to choose a material guaranteeing high mechani-
cal performances even in the presence of high porosity.
Many biomaterials have been used as scaffolds for cell
culture and they can be divided into four main cate-
gories: natural polymers, synthetic polymers, biocera-
mics and composites (9, 13). Each class presents
advantages and disadvantages that the biomaterialist
must take into account in relation to the application
field of interest.
In the next sections we list the main biomaterials in
each class, and outline their main advantages, disad-
vantages and application fields.
Natural polymers
Natural polymers have been and continue to be the
materials most used for scaffold fabrication because of
their great similarity to the extracellular matrix struc-
ture and their biocompatibility and biodegradability
(9). In fact, they can easily be modified, degraded and
absorbed in vivo by enzymes naturally present in the
human body (14). 
Natural polymers are derived mainly from animal
sources, but vegetable sources have also been investi-
gated (15, 16). Among the large number of natural
polymers of animal origin some have attracted parti-
cular interest in recent years, namely: collagen, gelatin,
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silk and chitosan. Instead, cellulose, alginate, agarose
and cornstarch have been explored as potential scaf-
folds of vegetable origin.
Collagen is probably the most widely used natural
polymer for TE applications. Many types of collagen
are available, and they differ in terms of their animal
source (i.e. bovine, equine, etc.) and zone of extraction
(i.e. derma, tendon etc.). Collagen offers numerous
advantages; first of all, it is present in most natural tis-
sues, being the main component of connective tissue
and the most abundant protein in the body, but it has
the disadvantage of degrading very fast and at a quite
uncontrolled rate, which reduces its mechanical
strength (13). Crosslink treatments, thermal or chemi-
cal, can be performed in order to extend its durability
in body fluids and increase its mechanical performan-
ce. Alternatively, composites made of collagen and a
reinforcing phase, such as hydroxyapatite, have been-
widely proposed to improve the mechanical strength
of the material (17-19).
When collagen is irreversibly hydrolyzed, gelatin is
obtained. In very recent years, gelatin has been the
focus of numerous investigations because it offers two
important advantages: low cost and simple prepara-
tion (20). Because of its poor mechanical resistance,
gelatin, especially in orthopedic applications, is usually
used in combination with other materials, such as
hydroxyapatite, bioactive glass, hyaluronic acid and
chitosan (16, 20-22).
Silks are fibrous proteins produced by several species
such as lepidoptera, mites, flies and spiders. In the last
ten years, silks have been proposed as new scaffold bio-
materials for TE applications due to their physical pro-
perties: they are stable, flexible and very resistant in
tension and compression (23, 24). Because of the
above-mentioned properties, silk-based scaffolds have
been evaluated in depth for skeletal TE applications
such as, for example, cartilage and bone regeneration
(25-27). The main disadvantage of silk is the very low
speed of spider production.
Chitosan is obtained by the alkaline deacetylation of
chitin, the world’s second most abundant natural poly-
saccharide after cellulose. Chitin is extracted from exo-
skeletons of crustaceans and from cell walls of fungi or
insects. Chitosan presents important properties that
undoubtedly make it a biomolecule offering great
potential for regenerative medicine. Among the several
properties of chitosan we cite its biodegradability, high
adsorption capacity, gel forming ability and the pre-
sence of reactive functional groups (28). 
Synthetic polymers
Although natural polymers are currently the materials
most extensively used in the fabrication of scaffolds,
synthetic polymers have been and continue to be
widely used since they have good mechanical strength,
reproducible/controllable mechanical-chemical pro-
perties, and controllable biodegradation rates. 
Synthetic polymers can be divided in two classes: bio-
degradable, such as poly(glycolic), poly(lactic)acid and
copolymers, polycaprolactone, polydioxanone, and pol-
yurethanes, and non-biodegradeable, such as polyvinyl
alcohol, polyhydroxyethymethacrylate, and poly(N-iso-
propylacrylamide). 
However, because the most common synthetic poly-
mers have ahydrophobic nature, they show poor wet-
ting properties that result in poor cell distribution and
poor cell adhesion. Moreover, synthetic polymers can
cause systemic or local reactions caused by acidic
degradation products.
In order to improve the cell affinity of these materials,
surface treatments have recently been proposed and
are currently under examination by numerous investi-
gators (29, 30).
Bioceramics
A ceramic material used in a biomedical application
can be defined a bioceramic material. Bioceramics is
the science governing the production of solid ceramic
bodies, porous or dense, by the melting of raw inorga-
nic material (9). The main application field of bioce-
ramic materials is orthopedics because of the great affi-
nity of the chemical composition of some ceramic
materials with the mineral constituent of bones. The
bioceramic materials can be grouped into three classes
according to their behavior in the physiological envi-
ronment: (a) bioresorbable, i.e. calcium and three-cal-
cium phosphates, (b) bioactive or surface-active, i.e.
hydroxyapatite, (c) non-resorbable or inert, i.e. alumi-
na and zirconia. 
The main disadvantages of these materials are their














main advantagesare their high biocompatibility and
good osteconductivity.
Composites
One of the most interesting solutions currently under
evaluation in order to overcome some of the disadvan-
tages of the single-phase materials described above is
the combination of different materials to obtain a
composite. A composite material should increase the
performance of the single-phase materials that compo-
se it. Among the possible combinations, we cite: (a)
natural or synthetic polymer-ceramic, and (b) poly-
mer-polymer, both natural and synthetic. The main
advantage of a composite is that it can provide tailored
mechanical properties and degradation rates. The
main disadvantage is that the scaffold fabrication tech-
niques can be quite complicated.
Scaffold fabrication technologies
The spatial organization of tissue in the human body
is prevalently three-dimensional. For this reason, a
scaffold capable of restoring diseased or missing tissue
inside the body has to be three-dimensional too. The
aim of the most innovative technologies used for scaf-
fold fabrication is therefore to obtain three-dimensio-
nal structures with a high and a highly interconnected
porosity in order to resemble, as closely as possible, the
native tissue (31).
Numerous fabrication methods have been reported in
the literature over the past ten years. Of these, freeze
drying, particulate leaching, sponge replication, rapid
prototyping, gas foaming and microsphere sintering
are the most used and consolidated.
Freeze drying
In freeze drying, the material of interest is dispersed in
a liquid phase in order to obtain a solid phase homo-
genously dispersed in a liquid phase. The slurry is then
frozen and subsequently oven dried under high
vacuum conditions in order to allow the solid-gas
phase transformation. The result will be a highly
porous scaffold featuring high interconnection of the
porosity.
In order to control the percentage and orientation of
the porosity, pore size, architecture, and mechanical
properties, compositional and process parameters can
be varied (32). In this way, it is possible to obtain the
desired anisotropic orientation of the porosity (Fig. 2).
Particulate leaching
Particulate leaching consists of dissolving a polymeric
material in an organic solvent and adding particles,
usually salts, to the solution. The solution is then
poured into a mold and the solvent is allowed to eva-
porate. The polymer-particle composite material is
then placed in a bath able to dissolve the particles;
this results in a porous three-dimensional polymeric
structure. 
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This technique is widely used for the fabrication of
highly porous scaffolds made of synthetic polymers
(33).
Sponge replication
In order to obtain a highly porous three-dimensional
scaffold in a ceramic material the sponge replication
method can be used. This consists of impregnation of
a polymeric sponge with a ceramic slurry (ceramic
powder suspended in a liquid phase) and subsequent
heat treatment at high temperature of the infiltrated
sponge in order to allow burn-out of the sponge and,
following a further increase of the temperature, sinte-
ring of the ceramic. 
The result is a ceramic sponge that perfectly replicates
the geometry of the original sponge. Selecting or for-
ming a sponge having the geometry of interest, the
replication method makes it possible to obtain a cera-
mic scaffold having that exact same geometry (34)
(Fig. 3).
Rapid prototyping
Rapid prototyping is a technique that allows the quick
fabrication of three-dimensional parts starting from
CAD (computer-aided design) data. The fabrication
of the object is usually performed using three-dimen-
sional printing technologies such as fused deposition
modeling (FDM). FDM has the potential to design
and fabricate highly reproducible 3D scaffolds with
fully interconnected pore networks, building physical
models by depositing layers of a thermoplastic mate-
rial one at a time (35).
Gas foaming
The gas foaming process consists of pressurizing a
polymeric solution (in water or fluoroform) at high-
pressures with a gas-foaming agent, such as CO2 and
nitrogen, until the polymers are saturated. As a conse-
quence of the high pressurization, nucleation and
growth of gas bubbles will occur, generating pores insi-
de the polymeric structure. This technique has the
advantage of being an organic solvent-free process,
butthe drawback of generating structures with a basi-
cally unconnected porosity. For this reason, in the lite-
rature, the combination of gas foaming with salt lea-
ching techniques has been proposed (36).
Microsphere sintering
Microsphere sintering is a very simple technique in
which polymeric or ceramic microspheres falling
within a narrow size range are thermally fused together
to form a three-dimensional porous structure.This
structure can itself be used as a scaffold, or as synthe-
tic scaffold providing a negative template for, for
example, bone regeneration (37) (Fig. 4).
Fig. 3. An example of a hydroxyapatite scaffold obtained using the sponge replication method. A picture of the scaffold (left) and SEM image of














Although the above illustrated techniques make it pos-
sible to obtain geometries of increasing complexity
using innovative materials, the resulting scaffolds are
still not able to actively modulate cell behavior or
mimic the complex interaction between the cells of a
specific tissue and the extracellular matrix of that spe-
cific tissue.
The capacity to develop active scaffolds that are able to
‘dialogue’ with cells is important in order to achieve
significant advancement of the TE field. In order to
obtain such smart scaffolds the currently used scaffold
fabrication technologies must be integrated with the
more innovative techniques of surface modification.
In the last few years, the importance of the properties
of the scaffold surface, together with the possibility of
modifying it, has emerged as a key factor in TE advan-
cement. 
Numerous investigators are currently working on scaf-
fold surface treatment via plasma or using nanotech-
nologies in order (a) to modify the surface to improve
the affinity between cell and substrate (i.e. hydrophili-
zation of hydrophobic material), (b) to cover the sur-
face with a more affine material by deposition, (c) to
add receptor sites to the surface in order to link
drug/growth factor release systems (38).
In conclusion, we still do not have the perfect scaffold
for each TE application. Moreover, the fabrication
techniques so far developed are still not able to give us
an active, smart scaffold capable of dialoguing with
cells. However, the most recent surface treatment tech-
niques based mostly on nanoscale technologies will
surely offer new and very promising solutions repre-
senting a step forward in the TE field (39).
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